AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8904327 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g EACA upon initiation of cardiopulmonary bypass (CPB)
Number of subjects: 46
Study 8904327 — intervention group
Group type: COMPARATOR
Intervention: No antifibrinolytic drugs prior to CPB
Number of subjects: 46
Study 1885077 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling on a bicycle ergometer for 1 hour every day
Number of subjects: 10
Study 1885077 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging on a treadmill for 1 hour every day
Number of subjects: 10
Study 1885077 — intervention group
Group type: COMPARATOR
Intervention: Resting in a chair for 1 hour every day
Number of subjects: 10
Study 6864291 — intervention group
Group type: EXPERIMENTAL
Intervention: Discectomy without fusion (DE)
Number of subjects: 63
Study 6864291 — intervention group
Group type: COMPARATOR
Intervention: Discectomy with fusion (DEF)
Number of subjects: 63
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's primary education
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary (9+) education
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Husband's primary education
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Husband's secondary (9+) education
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about RHR
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Marriage duration of more than 10 years
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to micro‐credit enterprises
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Having gender equitable attitude
Number of subjects: 415
Study 31665037 — intervention group
Group type: EXPERIMENTAL
Intervention: Good qualities of spousal relation
Number of subjects: 415
Study 30571418 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 70
Study 30571418 — intervention group
Group type: EXPERIMENTAL
Intervention: DOACs (various)
Number of subjects: 70
Study 30571418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 70
Study 30571418 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 70
Study 30571418 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 70
Study 27002280 — intervention group
Group type: EXPERIMENTAL
Intervention: PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg)
Number of subjects: 0
Study 27002280 — intervention group
Group type: COMPARATOR
Intervention: EC-ASA (enteric-coated aspirin 325 mg)
Number of subjects: 0
Study 24385131 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low doses of ethanol (<5 mM blood concentration)
Number of subjects: 9
Study 24385131 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of alprazolam
Number of subjects: 9
Study 24385131 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of zolpidem
Number of subjects: 9
Study 24385131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 22179861 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (NSAID)
Number of subjects: 6
Study 22179861 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone (Opioid)
Number of subjects: 6
Study 20122176 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme including peer discussions, with eight pages of written material and a two-hour face-to-face discussion session.
Number of subjects: 74
Study 20122176 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme including peer discussions.
Number of subjects: 74
Study 20122176 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational programme).
Number of subjects: 74
Study 17071932 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-field radiotherapy (EF-RT) 30 Gy + 10 Gy to bulky disease
Number of subjects: 1064
Study 17071932 — intervention group
Group type: COMPARATOR
Intervention: Involved-field radiotherapy (IF-RT) 30 Gy + 10 Gy to bulky disease
Number of subjects: 1064
Study 14693590 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg 2% preservative-free 2-chloroprocaine
Number of subjects: 8
Study 14693590 — intervention group
Group type: COMPARATOR
Intervention: 40 mg 2% lidocaine
Number of subjects: 8
Study 12378742 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone + proguanil combination
Number of subjects: 0
Study 12378742 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone + proguanil prophylaxis
Number of subjects: 0
Study 9828793 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 60
Study 9828793 — intervention group
Group type: EXPERIMENTAL
Intervention: EUA
Number of subjects: 60
Study 9828793 — intervention group
Group type: EXPERIMENTAL
Intervention: TRU
Number of subjects: 60
Study 10171932 — intervention group
Group type: EXPERIMENTAL
Intervention: ComputerLink project intervention providing information and support to caregivers
Number of subjects: 0
Study 2547950 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (10 to 40 mg daily)
Number of subjects: 32
Study 2547950 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (25 to 100 mg daily)
Number of subjects: 32
Study 327854 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (5 mg)
Number of subjects: 280
Study 327854 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine HCl (50 mg)
Number of subjects: 280
Study 327854 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 280
Study 327854 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 280
Study 31788318 — intervention group
Group type: EXPERIMENTAL
Intervention: Dotinurad (0.5-20 mg single-dose administration)
Number of subjects: 0
Study 31788318 — intervention group
Group type: EXPERIMENTAL
Intervention: PK/PD model predictions
Number of subjects: 0
Study 26480553 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding therapy applied to Qugu (CV 2), Shenshu (BL 23), Zhibian (BL 54), Huiyin (CV 1) and Sanyinjiao (SP 6), once every two weeks for 4 weeks, with two sessions total.
Number of subjects: 180
Study 26480553 — intervention group
Group type: COMPARATOR
Intervention: Western medication group: tamsulosin capsules 0.2 mg once daily and indometacin sustained release tablets 25 mg three times daily for 8 weeks.
Number of subjects: 180
Study 23890958 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban Circuits Group (UCG)
Number of subjects: 83
Study 23890958 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Group (NCG)
Number of subjects: 83
Study 23890958 — intervention group
Group type: COMPARATOR
Intervention: Control Group (not enrolled in rehabilitation program)
Number of subjects: 83
Study 21457390 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile gloves
Number of subjects: 60
Study 21457390 — intervention group
Group type: COMPARATOR
Intervention: Clean, nonsterile gloves
Number of subjects: 60
Study 21457390 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 60
Study 18841390 — intervention group
Group type: EXPERIMENTAL
Intervention: Parallel processing of two tasks
Number of subjects: 0
Study 18841390 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate degree of parallel processing
Number of subjects: 0
Study 18841390 — intervention group
Group type: COMPARATOR
Intervention: Serial processing of two tasks
Number of subjects: 0
Study 16202481 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine 0.3 mg
Number of subjects: 22
Study 16202481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 15279041 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 227
Study 15279041 — intervention group
Group type: COMPARATOR
Intervention: Usual care with first generation agents
Number of subjects: 227
Study 11726252 — intervention group
Group type: EXPERIMENTAL
Intervention: 5RM bench press before explosive push-ups
Number of subjects: 0
Study 11726252 — intervention group
Group type: COMPARATOR
Intervention: Explosive push-ups only
Number of subjects: 0
Study 9003214 — intervention group
Group type: EXPERIMENTAL
Intervention: Air at 37 degrees C and 90% RH
Number of subjects: 10
Study 9003214 — intervention group
Group type: COMPARATOR
Intervention: Air at 20 degrees C and 30% RH
Number of subjects: 10
Study 8305125 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH plus TRH administration
Number of subjects: 28
Study 8305125 — intervention group
Group type: COMPARATOR
Intervention: CRH alone
Number of subjects: 28
Study 3423736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking without cimetidine pretreatment
Number of subjects: 14
Study 3423736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking after cimetidine pretreatment (2 X 400 mg orally for 2 days and 400 mg orally 1.5 h before examination)
Number of subjects: 14
Study 30986958 — intervention group
Group type: EXPERIMENTAL
Intervention: Pistachios (56 g, 1318 kJ)
Number of subjects: 30
Study 30986958 — intervention group
Group type: COMPARATOR
Intervention: Savory biscuits (56 g, isoenergetic/equiprotein)
Number of subjects: 30
Study 28196772 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Group therapy (ACT‐G)
Number of subjects: 126
Study 26688585 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation first (90 students)
Number of subjects: 180
Study 26688585 — intervention group
Group type: COMPARATOR
Intervention: Clinic first (90 students)
Number of subjects: 180
Study 23706025 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted walking training
Number of subjects: 0
Study 23706025 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study 21592186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy gel wrap applied to lower leg skin for 30 minutes daily for four weeks
Number of subjects: 60
Study 21592186 — intervention group
Group type: COMPARATOR
Intervention: Standard care (compression and leg elevation)
Number of subjects: 60
Study 18269390 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 40
Study 18269390 — intervention group
Group type: COMPARATOR
Intervention: Starch solutions
Number of subjects: 40
Study 17278430 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (one course) for group B patients
Number of subjects: 141
Study 17278430 — intervention group
Group type: EXPERIMENTAL
Intervention: Total chemotherapy for group B patients
Number of subjects: 141
Study 17278430 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B patients (AML other than APL)
Number of subjects: 141
Study 17278430 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A patients (APL)
Number of subjects: 141
Study 17278430 — intervention group
Group type: EXPERIMENTAL
Intervention: Total AML patients
Number of subjects: 141
Study 15218815 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline and annual MRI evaluation
Number of subjects: 0
Study 11720698 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician's choice design
Number of subjects: 0
Study 11720698 — intervention group
Group type: EXPERIMENTAL
Intervention: Equipoise stratified design
Number of subjects: 0
Study 11720698 — intervention group
Group type: COMPARATOR
Intervention: Completely randomized designs
Number of subjects: 0
Study 8988796 — intervention group
Group type: EXPERIMENTAL
Intervention: AMPT with full-strength tryptophan-depleting amino acid drink
Number of subjects: 8
Study 8988796 — intervention group
Group type: COMPARATOR
Intervention: AMPT with tryptophan-supplemented amino acid drink
Number of subjects: 8
Study 8988796 — intervention group
Group type: COMPARATOR
Intervention: AMPT with 25% strength tryptophan-depleting amino acid drink
Number of subjects: 8
Study 8491007 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg daily)
Number of subjects: 300
Study 8491007 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumadin (with heparin until oral anticoagulation established)
Number of subjects: 300
Study 8491007 — intervention group
Group type: COMPARATOR
Intervention: Placebo (with discontinuation of heparin)
Number of subjects: 300
Study 3574990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized racemic epinephrine
Number of subjects: 45
Study 3574990 — intervention group
Group type: COMPARATOR
Intervention: Warmed, humidified gas
Number of subjects: 45
Study 30217640 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoactive medications
Number of subjects: 172
Study 30217640 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of vasoactive medication use (in days)
Number of subjects: 172
Study 30217640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative norepinephrine dose (μg/kg/d)
Number of subjects: 172
Study 30217640 — intervention group
Group type: COMPARATOR
Intervention: Vasopressin
Number of subjects: 172
Study 30217640 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 172
Study 26888712 — intervention group
Group type: EXPERIMENTAL
Intervention: DIET (25% daily needs energy deficits induced by diet only)
Number of subjects: 10
Study 26888712 — intervention group
Group type: EXPERIMENTAL
Intervention: EX (25% daily needs energy deficits induced by exercise only)
Number of subjects: 10
Study 24913338 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 12
Study 22081005 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (100 mg/day)
Number of subjects: 0
Study 22081005 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg/day)
Number of subjects: 0
Study 22081005 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan + Simvastatin (20 mg/day)
Number of subjects: 0
Study 22081005 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine + Simvastatin (20 mg/day)
Number of subjects: 0
Study 20171410 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbomer-based lipid-containing gel (CBLC)
Number of subjects: 30
Study 20171410 — intervention group
Group type: COMPARATOR
Intervention: HP-guar gel
Number of subjects: 30
Study 18165396 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (180 mg daily)
Number of subjects: 93
Study 18165396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 11576046 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.5% plain
Number of subjects: 200
Study 11576046 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.5% plus hyaluronidase 100 i.u. ml‐1
Number of subjects: 200
Study 11576046 — intervention group
Group type: COMPARATOR
Intervention: lidocaine 2% plus epinephrine 1:200 000
Number of subjects: 200
Study 11576046 — intervention group
Group type: COMPARATOR
Intervention: mixture of lidocaine 2% and bupivacaine 0.5% (2:3 volume per volume) containing hyaluronidase 25 i.u. ml‐1
Number of subjects: 200
Study 9581985 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (150 mg caffeine)
Number of subjects: 12
Study 9581985 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee
Number of subjects: 12
Study 9581985 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 kcal meal
Number of subjects: 12
Study 9581985 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 9581985 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 12
Study 8140940 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF at 75 mg/day
Number of subjects: 202
Study 8140940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 3395500 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly prescription for BSE
Number of subjects: 51
Study 3395500 — intervention group
Group type: EXPERIMENTAL
Intervention: Every-two-weeks prescription for BSE
Number of subjects: 51
Study 3395500 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly prescription for BSE
Number of subjects: 51
Study 29891419 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M True Definition Scanner (TDS)
Number of subjects: 30
Study 29891419 — intervention group
Group type: EXPERIMENTAL
Intervention: cara TRIOS (Trios)
Number of subjects: 30
Study 29891419 — intervention group
Group type: COMPARATOR
Intervention: Impregum Penta Soft (Impregum)
Number of subjects: 30
Study 28626213 — intervention group
Group type: EXPERIMENTAL
Intervention: Imrecoxib 200 mg twice daily
Number of subjects: 60
Study 28626213 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg twice daily
Number of subjects: 60
Study 28626213 — intervention group
Group type: EXPERIMENTAL
Intervention: Imrecoxib
Number of subjects: 60
Study 28626213 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 60
Study 24978157 — intervention group
Group type: EXPERIMENTAL
Intervention: Education-support intervention delivered in the home setting for 9 months
Number of subjects: 50
Study 24978157 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study 23747130 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick latex surgical gloves
Number of subjects: 70
Study 23747130 — intervention group
Group type: COMPARATOR
Intervention: Conventional gloves
Number of subjects: 70
Study 21194988 — intervention group
Group type: EXPERIMENTAL
Intervention: Puncture site at lateral malleolar part of the SSV (Group 1)
Number of subjects: 60
Study 21194988 — intervention group
Group type: COMPARATOR
Intervention: Puncture site at mid-calf (Group 2)
Number of subjects: 60
Study 19083555 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction mammaplasty
Number of subjects: 100
Study 19083555 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 100
Study 16575010 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine (25 mg/m2 IV daily for 5 days every 4 weeks)
Number of subjects: 381
Study 16575010 — intervention group
Group type: COMPARATOR
Intervention: CVP (cyclophosphamide 750 mg/m2 IV on day 1; vincristine 1.4 mg/m2 IV on day 1; prednisone 40 mg/m2 orally on days 1-5 every 4 weeks)
Number of subjects: 381
Study 12742332 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg)
Number of subjects: 3294
Study 12742332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3294
Study 10690763 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional insemination (25,000 sperm, prolonged contact 16-24 h)
Number of subjects: 0
Study 10690763 — intervention group
Group type: EXPERIMENTAL
Intervention: Short insemination protocol (25,000 sperm, limited to 2 h)
Number of subjects: 0
Study 10690763 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI, 1 sperm injected)
Number of subjects: 0
Study 10690763 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer (ET)
Number of subjects: 0
Study 10690763 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer (ET)
Number of subjects: 0
Study 9139174 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of hot red pepper
Number of subjects: 0
Study 9139174 — intervention group
Group type: COMPARATOR
Intervention: Standard meal without hot red pepper (control)
Number of subjects: 0
Study 8444361 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery based on prism-adapted angle (32 patients)
Number of subjects: 77
Study 8444361 — intervention group
Group type: COMPARATOR
Intervention: Surgery based on initially measured angle (31 patients)
Number of subjects: 77
Study 8444361 — intervention group
Group type: COMPARATOR
Intervention: Surgery based on angle before prism correction (14 patients)
Number of subjects: 77
Study 30626253 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegaspargase given intravenously
Number of subjects: 0
Study 29735470 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ulcer powder combined with Kangfuxin liquid
Number of subjects: 0
Study 29735470 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 26677992 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Therapeutic Education (PTE)
Number of subjects: 54
Study 26677992 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 54
Study 25558700 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee SPECT scan
Number of subjects: 193
Study 25558700 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee MRI
Number of subjects: 193
Study 25558700 — intervention group
Group type: COMPARATOR
Intervention: Comparison with arthroscopy (gold standard)
Number of subjects: 193
Study 22759259 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite (CaHA) injections
Number of subjects: 116
Study 21180368 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 448
Study 21180368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 448
Study 18190562 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linked collagen membranes (CLM)
Number of subjects: 52
Study 18190562 — intervention group
Group type: COMPARATOR
Intervention: Non-cross-linked collagen membranes (NCLM)
Number of subjects: 52
Study 16731465 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-chamber pacing (DDDR)
Number of subjects: 2010
Study 16731465 — intervention group
Group type: COMPARATOR
Intervention: Ventricular pacing (VVIR)
Number of subjects: 2010
Study 12595874 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial electrostimulation treatment (TCET)
Number of subjects: 0
Study 12595874 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 11013193 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium 0.1% (20 patients)
Number of subjects: 40
Study 11013193 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 0.1% (20 patients)
Number of subjects: 40
Study 8628597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 10 mg/d
Number of subjects: 69
Study 8628597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg/d
Number of subjects: 69
Study 8628597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 30 mg/d
Number of subjects: 69
Study 8628597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg/d
Number of subjects: 69
Study 8628597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (all doses)
Number of subjects: 69